- Home
- FCEL vs CRBU Comparison
FCEL vs CRBU Comparison
Compare FCEL & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCEL
- CRBU
- Stock Information
- Founded
- FCEL 1969
- CRBU 2011
- Country
- FCEL United States
- CRBU United States
- Employees
- FCEL N/A
- CRBU N/A
- Industry
- FCEL Industrial Machinery/Components
- CRBU Medicinal Chemicals and Botanical Products
- Sector
- FCEL Energy
- CRBU Health Care
- Exchange
- FCEL Nasdaq
- CRBU Nasdaq
- Market Cap
- FCEL 96.7M
- CRBU 93.0M
- IPO Year
- FCEL 1992
- CRBU 2021
- Fundamental
- Price
- FCEL $4.28
- CRBU $0.77
- Analyst Decision
- FCEL Hold
- CRBU Strong Buy
- Analyst Count
- FCEL 6
- CRBU 5
- Target Price
- FCEL $14.28
- CRBU $10.60
- AVG Volume (30 Days)
- FCEL 695.9K
- CRBU 1.0M
- Earning Date
- FCEL 06-09-2025
- CRBU 05-08-2025
- Dividend Yield
- FCEL N/A
- CRBU N/A
- EPS Growth
- FCEL N/A
- CRBU N/A
- EPS
- FCEL N/A
- CRBU N/A
- Revenue
- FCEL $114,438,000.00
- CRBU $9,918,000.00
- Revenue This Year
- FCEL $42.70
- CRBU N/A
- Revenue Next Year
- FCEL $10.61
- CRBU $163.34
- P/E Ratio
- FCEL N/A
- CRBU N/A
- Revenue Growth
- FCEL 11.09
- CRBU N/A
- 52 Week Low
- FCEL $3.58
- CRBU $0.66
- 52 Week High
- FCEL $30.90
- CRBU $4.21
- Technical
- Relative Strength Index (RSI)
- FCEL 51.22
- CRBU 43.66
- Support Level
- FCEL $3.58
- CRBU $0.73
- Resistance Level
- FCEL $4.32
- CRBU $0.91
- Average True Range (ATR)
- FCEL 0.28
- CRBU 0.08
- MACD
- FCEL 0.11
- CRBU 0.01
- Stochastic Oscillator
- FCEL 68.42
- CRBU 24.34
About FCEL FuelCell Energy Inc.
FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products and electrolysis platforms that decarbonize power and produce hydrogen. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company operates in USA, South Korea, Europe and Canada. Majority of revenue is from USA and South Korea.
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.